GlassScriptPhysician profile
Peter B Petratos
NPI 1487612297
$5,086.51
in general payments reported to CMS, 2019-2025
11 companies · $3,362 in 2025
The $3,362 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $293 · 2021: $297 · 2022: $204 · 2023: $404 · 2024: $165 · 2025: $3,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $931.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,884.54 | 2019-2025 | |
| Ethicon US, LLC | $661.08 | 2021-2023 | Echelon; Endopath, Vistaseal, Ethicon |
| Conmed Corporation | $128.45 | 2019-2024 | Airseal |
| Baxter Healthcare | $105.26 | 2024 | Perclot |
| Boston Scientific Corporation | $66.93 | 2023 | Spyglass |
| Erbe USA INC | $65.77 | 2019 | |
| Davol INC. | $63.81 | 2019-2020 | |
| Coopersurgical, INC. | $38.46 | 2019 | |
| Kerecis Limited | $30.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| W. L. Gore & Associates, INC. | $23.92 | 2019 | |
| Medtronic, INC. | $18.26 | 2024 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Petratos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.